RNWL
INTERNATIONAL REGISTRATION RENEWED
12/18/2025
Back to search
Official data from USPTO
AFT PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AFT PHARMACEUTICALS
ST13
US500000079183211Class
5
Filing
79183211
Registration
5293339
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
12/19/2025
Trademark type
Word
Nice classes
5
Filing date
12/17/2015
Registration date
09/26/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2024
Last transaction
12/19/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Takapuna Auckland, NZ
Examiner
LEIPZIG,MARC J
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
AFT Pharmaceuticals Limited
AFT Pharmaceuticals Limited
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of symptoms of cold and flu; pharmaceutical preparations for the treatment of inflammatory diseasesinflammatory bowel diseasesinflammatory connective tissue diseases; pharmaceutical preparations for pain relief; pharmaceutical preparationsantihistamines for relief of symptoms of allergies and allergic conditions; pharmaceutical preparations for the treatment of the musculo-skeletal systemconnective tissue diseasesbone diseasesspinal diseasesback painfracturessprainscartilage injuries; pharmaceutical preparationsnasal spray for treating symptoms of allergies and allergic conditions: pharmaceutical preparationsointment for treatment of scalp conditions and skin infections; pharmaceutical preparations for use in ocular disorders: pharmaceutical preparationsmoisturizing eye ointmenteye drops for treatment of conjunctivitis and symptoms of allergies; pharmaceutical preparationsgel for the treatment of oral conditions: pharmaceutical preparationsdietary supplements for general health and well-being ;pharmaceutical preparationslaxatives; pharmaceutical preparationslotions for the treatment of head lice; pharmaceutical preparationsanti-fungal nail lacquer; and cream for the relief of pain associated with osteoarthritis
Publications
History of USPTO decisions and trademark events.
54 publications found
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
06/06/2025
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/31/2025
INPC
INVALIDATION PROCESSED
03/31/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/16/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/27/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/27/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/27/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/27/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/16/2024
71AG
REGISTERED-SEC.71 ACCEPTED
05/16/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/15/2024
ES71
TEAS SECTION 71 RECEIVED
09/20/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/26/2022
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
08/03/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/29/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/10/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/13/2018
FIMP
FINAL DISPOSITION PROCESSED
01/13/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/26/2017
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
11/29/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/29/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
10/08/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/08/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/11/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/26/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/26/2017
PUBO
PUBLISHED FOR OPPOSITION
07/11/2017
GPNX
NOTIFICATION PROCESSED BY IB
07/08/2017
FAXX
FAX RECEIVED
06/25/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/21/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/21/2017
NPUB
NOTICE OF PUBLICATION
06/21/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/05/2017
CNEA
EXAMINERS AMENDMENT MAILED
05/24/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/24/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
05/24/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/24/2017
CNFR
FINAL REFUSAL MAILED
10/20/2016
CNFR
FINAL REFUSAL WRITTEN
10/19/2016
ACEC
AMENDMENT FROM APPLICANT ENTERED
09/28/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2016
ALIE
ASSIGNED TO LIE
09/22/2016
FAXX
FAX RECEIVED
09/14/2016
RFNT
REFUSAL PROCESSED BY IB
05/13/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/07/2016
RFRR
REFUSAL PROCESSED BY MPU
04/07/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/07/2016
CNRT
NON-FINAL ACTION WRITTEN
04/06/2016
DOCK
ASSIGNED TO EXAMINER
04/05/2016
MAFR
APPLICATION FILING RECEIPT MAILED
03/01/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/26/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/25/2016
Continuous trademark protection
Get notified about every new filing that threatens AFT PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.